ACAGT-007a, an ERK MAPK Signaling Modulator, in Combination with AKT Signaling Inhibition Induces Apoptosis in KRAS Mutant Pancreatic Cancer T3M4 and MIA-Pa-Ca-2 CellsGolam Iftakhar Khandakar, Reiko Sugiura|Cells|2022Cited by 13
<scp>ACAGT</scp>‐007a, an anti‐cancer compound that modulates <scp>ERK MAPK</scp> signaling, induces nuclear enrichment of phosphorylated <scp>ERK</scp> in <scp>T3M4</scp> pancreatic cancer cellsGolam Iftakhar Khandakar, Reiko Sugiura|Genes to Cells|2023Cited by 0